Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.
TipRanks on MSN
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...
The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...
Providence Holy Cross Medical Center is the first Providence hospital in the San Fernando Valley to offer a minimally ...
Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
On Wednesday, the FDA approved Verona Pharma plc’s (NASDAQ:VRNA) Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvayre is ...
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
lung xray_TS_159291221 Clinician awareness of COPD treatment guidelines has increased since 2007. Clinicians report multiple barriers preventing the diagnosis of chronic obstructive pulmonary disease ...
Chronic obstructive pulmonary disease (COPD) makes it hard to breathe. Narrowed airways can make you cough, wheeze, and feel short of breath. It can affect how you exercise, work, and do other daily ...
Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback